On 10/16/24, Ocular Therapeutix Inc (NASDAQ: OCUL) stock enjoyed a major increase of 12.1%, closing at $11.47. Moreover, exceptionally high trading volume at 204% of normal accompanied the advance. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 23.1% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be below the cost of capital, OCUL is expected to continue to be a modest Value Eraser.
Ocular Therapeutix has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Ocular Therapeutix has a very low Appreciation Score of 3 but a good Power Rating of 83, and the Negative Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment